Search research articles
Contact Us
Filters
Showing results (1-10 of 16) with videos related to
Page
of 2
Sort By:
Swiss Medical Weekly
|
September 21, 2010
Insights into molecular pathways for targeted therapeutics in acute leukemia
Vaia Stavropoulou, Laurent Brault, Juerg Schwaller
Hemasphere
|
November 15, 2019
The Impact of the Cellular Origin in Acute Myeloid Leukemia: Learning From Mouse Models
James Neil Fisher, Natarajaswamy Kalleda, Vaia Stavropoulou, et al.
Gene Regulation and Systems Biology
|
September 30, 2009
The MAPK signaling cascade is a central hub in the regulation of cell cycle, apoptosis and cytoskeleton remodeling by tripeptidyl-peptidase II
Ramakrishna Sompallae, Vaia Stavropoulou, Mathieu Houde, et al.
Molecular & Cellular Oncology
|
September 26, 2018
Aggressive leukemia driven by MLL-AF9
Vaia Stavropoulou, Antoine H F M Peters, Juerg Schwaller
Biochemical and Biophysical Research Communications
|
June 10, 2006
TPPII promotes genetic instability by allowing the escape from apoptosis of cells with activated mitotic checkpoints
Vaia Stavropoulou, Vanessa Vasquez, Biancastella Cereser, et al.
Cancer Research
|
March 1, 2005
Mitotic infidelity and centrosome duplication errors in cells overexpressing tripeptidyl-peptidase II
Vaia Stavropoulou, Jianjun Xie, Marie Henriksson, et al.
Cell Stem Cell
|
December 7, 2014
Estrogen signaling selectively induces apoptosis of hematopoietic progenitors and myeloid neoplasms without harming steady-state hematopoiesis
Abel Sánchez-Aguilera, Lorena Arranz, Daniel Martín-Pérez, et al.
Hemasphere
|
November 15, 2019
A Novel Inducible Mouse Model of <i>MLL-ENL</i>-driven Mixed-lineage Acute Leukemia
Vaia Stavropoulou, Marwa Almosailleakh, Hélène Royo, et al.
British Journal of Clinical Pharmacology
|
April 14, 2023
Ensovibep, a SARS-CoV-2 antiviral designed ankyrin repeat protein, is safe and well tolerated in healthy volunteers: Results of a first-in-human, ascending single-dose Phase 1 study
Nina Stojcheva, Stacy Gladman, Marianne Soergel, et al.
Nature Cancer
|
May 1, 2026
Tumor-localized CD40 agonism with MP0317, a FAP x CD40 DARPin, reprograms the tumor microenvironment in patients with advanced solid tumors: an open-label, nonrandomized, dose-escalation phase 1 study
Neeltje Steeghs, Carlos Gomez-Roca, Iphigénie Korakis, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 16) with videos related to
Sort By:
Page
of 2
Swiss Medical Weekly
|
September 21, 2010
Insights into molecular pathways for targeted therapeutics in acute leukemia
Vaia Stavropoulou, Laurent Brault, Juerg Schwaller
Hemasphere
|
November 15, 2019
The Impact of the Cellular Origin in Acute Myeloid Leukemia: Learning From Mouse Models
James Neil Fisher, Natarajaswamy Kalleda, Vaia Stavropoulou, et al.
Gene Regulation and Systems Biology
|
September 30, 2009
The MAPK signaling cascade is a central hub in the regulation of cell cycle, apoptosis and cytoskeleton remodeling by tripeptidyl-peptidase II
Ramakrishna Sompallae, Vaia Stavropoulou, Mathieu Houde, et al.
Molecular & Cellular Oncology
|
September 26, 2018
Aggressive leukemia driven by MLL-AF9
Vaia Stavropoulou, Antoine H F M Peters, Juerg Schwaller
Biochemical and Biophysical Research Communications
|
June 10, 2006
TPPII promotes genetic instability by allowing the escape from apoptosis of cells with activated mitotic checkpoints
Vaia Stavropoulou, Vanessa Vasquez, Biancastella Cereser, et al.
Cancer Research
|
March 1, 2005
Mitotic infidelity and centrosome duplication errors in cells overexpressing tripeptidyl-peptidase II
Vaia Stavropoulou, Jianjun Xie, Marie Henriksson, et al.
Cell Stem Cell
|
December 7, 2014
Estrogen signaling selectively induces apoptosis of hematopoietic progenitors and myeloid neoplasms without harming steady-state hematopoiesis
Abel Sánchez-Aguilera, Lorena Arranz, Daniel Martín-Pérez, et al.
Hemasphere
|
November 15, 2019
A Novel Inducible Mouse Model of <i>MLL-ENL</i>-driven Mixed-lineage Acute Leukemia
Vaia Stavropoulou, Marwa Almosailleakh, Hélène Royo, et al.
British Journal of Clinical Pharmacology
|
April 14, 2023
Ensovibep, a SARS-CoV-2 antiviral designed ankyrin repeat protein, is safe and well tolerated in healthy volunteers: Results of a first-in-human, ascending single-dose Phase 1 study
Nina Stojcheva, Stacy Gladman, Marianne Soergel, et al.
Nature Cancer
|
May 1, 2026
Tumor-localized CD40 agonism with MP0317, a FAP x CD40 DARPin, reprograms the tumor microenvironment in patients with advanced solid tumors: an open-label, nonrandomized, dose-escalation phase 1 study
Neeltje Steeghs, Carlos Gomez-Roca, Iphigénie Korakis, et al.
Page
of 2